Fusion Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
Fusion Pharmaceuticals Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Five of $1.31 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2024-03-20
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $1.31M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $476.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $1.47M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2023-12-31 | $1.31M 10-K · filed 2024-03-20 |
| 2022-12-31 | $476.00K 10-K · filed 2023-03-16 |
| 2021-12-31 | $1.47M 10-K · filed 2022-03-17 |